WallStreetZenWallStreetZen

NASDAQ: RMTI
Rockwell Medical Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

RMTI past revenue growth

How has RMTI's revenue growth performed historically?
Company
14.84%
Industry
10.23%
Market
16.96%
RMTI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
RMTI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
RMTI's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

RMTI earnings and revenue history

Current Revenue
$83.6M
Current Earnings
-$8.4M
Current Profit Margin
-10.1%

RMTI Return on Equity

Current Company
-52%
Current Industry
15.4%
Current Market
188%
RMTI's Return on Equity (-52%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when RMTI announces earnings.

RMTI Return on Assets

Current Company
-18.4%
Current Industry
3.4%
RMTI is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

RMTI Return on Capital Employed

Current Company
-17.27%
Current Industry
5.1%
RMTI has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RMTI vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
RMTI$83.61M-$2.68M-$8.44M+5.69%N/A
CYTH$1.08M-$20.04M-$20.06M+1.25%N/A
BGXX$0.00-$12.49M-$13.13MN/AN/A
IXHL$0.00N/A-$17.42M-100.00%N/A
SCYX$140.14M$70.89M$67.04M+252.64%N/A
View Top Pharmaceutical Stocks

RMTI earnings dates

Next earnings date
May 14, 2024

Rockwell Medical Earnings & Revenue FAQ

What were RMTI's earnings last quarter?

On Invalid Date, Rockwell Medical (NASDAQ: RMTI) reported Q4 2023 earnings per share (EPS) of -$0.05, up 0% year over year. Total Rockwell Medical earnings for the quarter were -$1.51 million. In the same quarter last year, Rockwell Medical's earnings per share (EPS) was -$0.05.

If you're new to stock investing, here's how to buy Rockwell Medical stock.

What was RMTI's earnings growth in the past year?

As of Q2 2024, Rockwell Medical's earnings has grown year over year. Rockwell Medical's earnings in the past year totalled -$8.44 million.

What is RMTI's earnings date?

Rockwell Medical's earnings date is Invalid Date. Add RMTI to your watchlist to be reminded of RMTI's next earnings announcement.

What was RMTI's revenue last quarter?

On Invalid Date, Rockwell Medical (NASDAQ: RMTI) reported Q4 2023 revenue of $22.09 million up 14.39% year over year. In the same quarter last year, Rockwell Medical's revenue was $19.31 million.

What was RMTI's revenue growth in the past year?

As of Q2 2024, Rockwell Medical's revenue has grown 14.84% year over year. This is 4.61 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.23%. Rockwell Medical's revenue in the past year totalled $83.61 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.